Compare ACB & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACB | NAGE |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.3M | 212.8M |
| IPO Year | 2016 | 2010 |
| Metric | ACB | NAGE |
|---|---|---|
| Price | $4.07 | $2.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $4.29 | ★ $12.08 |
| AVG Volume (30 Days) | ★ 986.4K | 535.9K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | N/A | $2.91 |
| Revenue Next Year | $9.38 | $16.17 |
| P/E Ratio | ★ N/A | $27.83 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $2.56 | $2.39 |
| 52 Week High | $6.36 | $7.95 |
| Indicator | ACB | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 30.80 |
| Support Level | $3.75 | N/A |
| Resistance Level | $4.15 | $3.61 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 43.00 | 8.06 |
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.